The TRACEQUS Project, the result of the synthesis of research conducted by the Genodics Research Institute and the Kennebunk Research Institute in Maine, represents a major advance in the field of sound frequency therapy .

By identifying the specific frequencies of five natural molecules known for their effectiveness against cancer - Curcumin, Resveratrol, Epigallocatechin-3-gallate, Quercetin and Sulforaphane - the TRACEQUS Project aims to exploit their therapeutic potential to support individuals in their process of self-healing and well-being .

This innovative approach, based on the combination of advances in scientific research and the principles of bioacoustics , offers a new avenue in complementary support for cancer treatment.

By acting at the molecular level , these sound frequencies can disrupt the deregulated cellular processes associated with the disease, thus offering a complementary and non-invasive approach to support patients in their fight against cancer.

The TRACEQUS Project thus represents hope for those facing this disease , by offering an innovative and promising solution to improve their quality of life and their chances of recovery.